Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth S Thomson

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|February 26, 2010
Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issuesKenneth S Thomson
Antimicrobial Agents and Chemotherapy|June 16, 2012
Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniaeKenneth S Thomson
Journal of Clinical Microbiology|April 14, 2017
The Immaculate Carbapenemase StudyKenneth S Thomson
Current Pharmaceutical Design|August 17, 2012
Detection of gram-negative β-lactamase producing pathogens in the clinical labKenneth S Thomson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2013
Lowering of third generation cephalosporin breakpointsKenneth S Thomson
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 1997
A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM- and SHV-derived extended-spectrum beta-lactamasesKenneth S. Thomson, Christine C. Sanders
The Journal of Antimicrobial Chemotherapy|June 18, 2004
CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosaKenneth S Thomson, Ellen Smith Moland
Antimicrobial Agents and Chemotherapy|April 11, 2013
Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological originsKenneth S Thomson, Richard V Goering
Diagnostic Microbiology and Infectious Disease|April 6, 2005
Cefdinir: an oral alternative to parenteral cephemsArchana Chatterjee, Ellen S Moland, Kenneth S Thomson
Plos One|December 12, 2019
CPO Complete, a novel test for fast, accurate phenotypic detection and classification of carbapenemasesGina K Thomson, Sameh AbdelGhani, Kenneth S Thomson
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|February 26, 2010
Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issuesKenneth S Thomson
Antimicrobial Agents and Chemotherapy|June 16, 2012
Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniaeKenneth S Thomson
Journal of Clinical Microbiology|April 14, 2017
The Immaculate Carbapenemase StudyKenneth S Thomson
Current Pharmaceutical Design|August 17, 2012
Detection of gram-negative β-lactamase producing pathogens in the clinical labKenneth S Thomson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2013
Lowering of third generation cephalosporin breakpointsKenneth S Thomson
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 1997
A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM- and SHV-derived extended-spectrum beta-lactamasesKenneth S. Thomson, Christine C. Sanders
The Journal of Antimicrobial Chemotherapy|June 18, 2004
CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosaKenneth S Thomson, Ellen Smith Moland
Antimicrobial Agents and Chemotherapy|April 11, 2013
Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological originsKenneth S Thomson, Richard V Goering
Diagnostic Microbiology and Infectious Disease|April 6, 2005
Cefdinir: an oral alternative to parenteral cephemsArchana Chatterjee, Ellen S Moland, Kenneth S Thomson
Plos One|December 12, 2019
CPO Complete, a novel test for fast, accurate phenotypic detection and classification of carbapenemasesGina K Thomson, Sameh AbdelGhani, Kenneth S Thomson
Pageof 5